UNJHA FORMULATIONS LTD. Share Price

UNJHA FORMULATIONS LTD. Share Price

BSE: 531762
|
Pharmaceuticals
|
S Cap
₹ 33.68
+0.00 (0.00%)
1D
Last updated 11 Sep, 2026, 15:15 IST

UNJHA FORMULATIONS LTD. Share Price Today

As of 15 Sep 2026, UNJHA FORMULATIONS LTD. share price is ₹33.68. The stock opened at ₹32.00, compared to its previous close of ₹33.68. During today's trading session, UNJHA FORMULATIONS LTD. share price moved in the range of ₹32.00 to ₹33.68, with an average price of ₹32.84 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.52 and a high of ₹36.38.

₹32.00
0.00% up today
₹33.68
1D LOW
1D HIGH

UNJHA FORMULATIONS LTD. Returns Calculator

Circuit
L
H
₹32.00
₹35.36
52-week
L
H
₹17.52
₹36.38

About UNJHA FORMULATIONS LTD.

UNJHA FORMULATIONS LTD. Share Price
ISIN
INE576D01015
Sector Market Cap
₹ 15.09 Cr

Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabgol (psyllium) powder and is tested at its plant with a modern and well equipped physico chemical and micro biological quality control laboratory. The Company’s Anchor Sat-Isabgol is available in 50 grams (gms), 100 gm, 200 gm, and 400 gm. Its isabgo husk formulation is available in the elaichi flavor. The Company’s Fibron is available in 100 gms and 300 gms. Its Isabgol Poder is available in the orange flavor. Its Fibron SF (sugar-free) is available in 100 gm and 300 gm.

UNJHA FORMULATIONS LTD. Financial Highlights

  • Revenue: UNJHA FORMULATIONS LTD. reported revenue of ₹15.75 crore in FY26 vs ₹13.98 crore in FY25. It showed an increase of 12.66% on a yearly basis.
  • Operating Profit: UNJHA FORMULATIONS LTD. reported an operating profit of ₹0.95 crore in FY26 vs ₹0.52 crore in FY25. It showed an increase of 82.69% on a year-on-year basis.
  • Net Profit: UNJHA FORMULATIONS LTD. reported a net profit of ₹0.70 crore in FY26 vs ₹0.41 crore in FY25. It showed an increase of 70.73% on a yearly basis.

UNJHA FORMULATIONS LTD. Quarterly Result Highlights

  • UNJHA FORMULATIONS LTD. reported revenue of ₹3.31 crore in Jun 2026, compared with ₹3.33 crore in Mar 2026, representing a decrease of 0.60% on a quarter-on-quarter (QoQ) basis.
  • UNJHA FORMULATIONS LTD. reported an operating profit of ₹0.16 crore in Jun 2026, compared with ₹0.49 crore in Mar 2026, representing an increase of 132.65% on a quarter-on-quarter (QoQ) basis.
  • UNJHA FORMULATIONS LTD. reported a profit of ₹0.16 crore in Jun 2026, compared with ₹0.74 crore in Mar 2026, reflecting an increase of 121.62% on a QoQ basis.
  • The earnings per share (EPS) of UNJHA FORMULATIONS LTD. stood at ₹1.57 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
36.93%
FII
0.00%
Other DII
0.00%
Retail and other
63.07%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
15.09
P/E
32.08
P/B
3.93
ROE
18.34%
D/E
0.00
ROCE
25.02%
Div. Yield
0.00%
EPS(TTM)
1.57
Turnover
2.77
EV/EBITDA
15.28
Net Margin
4.49%
Op. Margin
7.12%
ROA
8.71%
Quick Ratio
2.15
Curr. Ratio
2.53
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Unjha Formul. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Unjha Formul. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

UNJHA FORMULATIONS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹15.59₹13.86₹18.50₹13.15
Other Income₹0.16₹0.11₹0.01₹0.03
Total Revenue₹15.75₹13.98₹18.51₹13.18
Total Expenses₹14.79₹13.45₹18.06₹12.85
Profit Before Tax₹0.95₹0.52₹0.45₹0.33
Tax₹0.25₹0.12₹0.17₹0.05
Profit After Tax₹0.70₹0.41₹0.28₹0.28
EPS - Basic₹1.57₹0.91₹0.62₹0.63
EPS - Diluted₹1.57₹0.91₹0.62₹0.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.95₹0.52₹0.45₹0.33
Income before WC changes₹1.12₹0.60₹0.59₹0.46
Change in Assets₹0.42₹0.30-₹0.64-₹0.35
Change in Liabilities-₹0.06-₹0.80₹1.12-₹0.33
Change in WC₹0.36-₹0.50₹0.49-₹0.67
Cash flow from Operations₹1.24-₹0.04₹1.03-₹0.26
Cash flow from Investing-₹0.23-₹0.18-₹0.11-₹0.10
Cash flow from Financing-₹0.01-₹0.01-₹0.05-₹0.06
Total Cash Flow₹1.00-₹0.23₹0.86-₹0.42
Cash (Start of the year)₹0.64₹0.87₹0.01₹0.43
Cash (End of the year)₹1.64₹0.64₹0.87₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1.30₹1.20₹1.12₹1.10
Current Assets₹4.21₹3.35₹3.81₹2.31
Total Assets₹5.51₹4.56₹4.93₹3.41
Current Liabilities₹1.67₹1.41₹2.20₹0.96
Net Current Asset₹2.54₹1.94₹1.62₹1.36
Non-Current Liabilities₹0.00₹0.00₹0.01₹0.00
Equity Capital₹3.84₹3.14₹2.73₹2.45
Total Equity & Liabilities₹5.51₹4.56₹4.93₹3.41
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
33.68
1444
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1444
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.7
Neutral
ATR (14)
1.44
Neutral
STOCH(9,6)
69.59
Neutral
STOCH RSI (14)
70.44
Neutral
ADX(9)
29.74
Bearish
UO(9)
71.98
Bearish
ROC(12)
29.54
Bullish
WillR(14)
-22.92
Neutral
Period
Simple value
Exponential vaue
5D
33.75
33.2
10D
31.13
31.6
20D
28.56
29.64
50D
26.52
26.81
100D
23.19
24.78
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
UNJHA FORMULATIONS LTD. Share Price
UNJHA FORMULATIONS LTD.
Pharmaceuticals
Add Stock
Add Another

UNJHA FORMULATIONS LTD. Share Price FAQs

UNJHA FORMULATIONS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837